Actively Recruiting

Phase Not Applicable
Age: 19Years +
All Genders
NCT05557123

Mobile App for Improving Adherence of Rivoxaban (RIVOX-AF)

Led by Seoul National University Bundang Hospital · Updated on 2025-01-28

1042

Participants Needed

1

Research Sites

198 weeks

Total Duration

On this page

Sponsors

S

Seoul National University Bundang Hospital

Lead Sponsor

S

SAMJIN PHARM

Collaborating Sponsor

AI-Summary

What this Trial Is About

RIVOX-AF study is a prospective, multicenter, randomized controlled study in which patients with AF are allocated to medication-app group or conventional treatment group. The App based feed-back algorithm will provide the patients with check taking drug or reminding of taking drug.

CONDITIONS

Official Title

Mobile App for Improving Adherence of Rivoxaban (RIVOX-AF)

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with atrial fibrillation aged 19 years or older with one or more of the following conditions: heart failure, myocardial infarction, stable angina, hypertension, or diabetes mellitus
  • Patients can be enrolled at least 3 months after myocardial infarction or percutaneous coronary intervention
  • Patients who are currently taking or plan to take rivoxaban
  • Patients who are able to use a smartphone
Not Eligible

You will not qualify if you...

  • Creatinine clearance less than 15 ml/min
  • Moderate or severe mitral stenosis
  • History of mitral valve operation
  • Current alcohol abuse or history of alcohol abuse
  • Legal or psychiatric problems making the patient ineligible
  • Participation in another clinical study within 4 weeks
  • Declined to enroll in the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Seoul National University Bundang Hospital

Seongnam, South Korea, 13620

Actively Recruiting

Loading map...

Research Team

D

Dong-Ju Choi, MD, PhD

CONTACT

M

Minjae Yoon, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here